Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Geriatic Use There is no information on the use of tesamorelin in patients greater than 65 years of age with HIV and lipodystrophy Gender There is no FDA guidance on the use of Tesamorelin with respect to specific gender populations
doi: 10.1007/s00240-024-01628-6 17 PradhanPJanaKGhoshSDebnathBRoutSKRaiVKet al
CAS 682809-81-0 / 767286-83-9View product Cosmetic & SkinCertificate pendingGHK basicPrice$50.99Formats1 size Compare size options, price, and certificate status before opening the product record
This gene modulation effect extends to pathways related to wound response, growth factors, and anti-fibrotic mechanisms, making it of growing interest in regenerative biology studies
Current therapeutic approaches, such as disease-modifying anti-rheumatic drugs (DMARDs) and biologics, are limited by infection risks, poor tissue specificity, and suboptimal long-term efficacy, underscoring the need for novel therapies
